A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
Status:
Completed
Trial end date:
2011-07-21
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of brief induction therapy with a
chemotherapeutic regimen containing MabThera, followed by either maintenance therapy with
MabThera or no further therapy. The anticipated time on study treatment is 1-2 years, and the
target sample size is 100-500 individuals.